SlideShare a Scribd company logo
DR. ARTHI
POST GRADUATE
MD PHARMACOLOGY
RAJAH MUTHIAH MEDICAL COLLEGE
.
• CELLULAR MACROMOLECULAR COMPLEX WITH
WHICH ITHE DRUG INTERACTS TO ELICIT A
CELLULAR RESPONSE.
• DRUGS CAN ACT EXTRACELLULAR, CELLULAR AND
INTRACELLULAR.
RECEPTOR
• RECEPTOR - DRUG COMPLEX -EFFECTOR PROTEIN -
SIGNAL TRANSDUCTIONSMECHANISM
• AFFINITY ; INTRINSIC ACTIVITY OR EFFICACY
• AGONIST ; ANTAGONIST
• PARTIAL AGONIST ; INVERSE AGONIST
TERMS
TYPES OF RECEPTORS
1) G-PROTEIN COUPLED RECEPTORS (GPCR)
2) ION CHANNEL RECEPTORS - VOC AND ROC.
3) TRANS MEMBRANE RECEPTORS- RECEPTOR TYROSINE KINASES ;
JAK- STAT; SERINE-THREONINE;
TOLL-LIKE; TNF-α
cGMP RECEPTORS
4) NUCLEAR RECEPTORS - CYTOSOLIC AND NUCLEAR
G PROTEIN COUPLED
RECEPTORS(METABOTROPIC)
• 7 ALPHA HELICAL PROTEIN WITH
2 DOMAINS
• HETEROTRIMERIC MOLECULE- α,
β, ¥ SUBUNITS TIGHTLY BOUND
TOGETHER WHICH OCCURS IN
RESTING STATE
• EFFECTOR MECHANISMS
Effector Mechanism
G-
PROTEIN
cAMP
PHOSPHO
LIPASE-C
ION
CHANNELS
GS: ADENYLYL CYCLASE ACTIVATION, Ca
CHANNEL OPENING
Gi: ADENYLYL CYCLASE INHIBITON, K+
CHANNEL OPENING
Go: Ca CHANNEL INHIBITION
Gq: PHOSPHOLIPASE- C ACTIVATION- IP3
AND DAG.
GPCR
CYCLIC AMP
• IS A PROTOTYPE SECOND MESSENGER FROM ADENYLYL CYCLASE.
• cAMP INCREASED IN GS AND cAMP DECREASED IN Gi PATHWAYS.
WHEN LIGAND(Adrenaline) BINDS TO GPCR,
↓
GS-α +GTP
↓
ACTIVATES ADENYLYL CYCLASE
↓
CAMP IS FORMED
↓
PHOSPHOKINASE A
PHOSPHOKINASE A - PHOSPHORYLATES AND ALTERS THE FUNCTION OF MANY ENYMES, ION
CHANNELS, TRANSPORTERS, TRANSCRIPTION FACTORS, STRUCTURAL PROTEINS.
• β¥ DIMER- CAN REGULATE ION CHANNELS, PI3
KINASE
• cAMP FUNCTIONS:
a) cAMP RESPONSE ELEMENT BINDING PROTEIN
b) CYCLIC NUCLEOTIDE GATED CA2+CHANNEL,
PDES,SEVERAL ABC TRANSPORTERS MRP4 AND MRP5.
c) REGULATES GUANINE NUCLEOTIDE EXCHANGE
FACTORS (EPAC)
• TERMINATION - BY PDES INTRACELLULARLY BY PDE3
AND PDE4. WHEREAS CGMP BY PDE5.
PHOSPHOLIPASE C (PLC)
ACTIVATED GTP WITH Gq-α SUBUNIT
↓
PIP2 PHOSPHORYLATION BY PLC
↓
SECOND MESSENGERS IP3 AND DAG
↓
DAG REMAINS IN MEMBRANE
;ACTIVATES PKC ALONG WITH ↓
Ca2+.
IP3 MOBILISES Ca2+ FROM ER→Ca-
CALMODULIN COMPLEX→EFFECTS→MLCK
AND CCPK.
PL-C HAS 2 ISOFORMS
PLC-βACTIVATED BY GPCR
PLC-¥ACTIVATED BY TYROSINE
PHOSPHORYLATION
ION CHANNELS
ACTIVATED G- PROTEIN OPEN OR INHIBIT Ca OR K CHANNELS
WITHOUT SECOND MESSENGERS.
eg: M2 RECEPTORS IN CARDIAC - ↑ K+ PERMEABILITY.
OPIODS REDUCE NEURONAL EXCITABILTY- K+ OPENING
MUSCARINIC M1,M3, M5
M2, M4
Gq
Gi,Go
ADRENERGIC ɑ1
ɑ2
β
Gq
Gi,Go
Gs
DOPAMINE D1
D2
Gs
Gi,Go
SEROTONIN 5HT1
5HT2
Gi,Go
Gq
ION CHANNEL RECEPTORS
VOC ROC
• MODULATED BY ALTERATIONS IN
VOLTAGE GRADIENT
• 3 STATES: OPEN
CLOSED/BLOCKED
INACTIVATED/REFRACTORY
eg: Na+ channel; K +channel; Ca2+
channel
• CHANNEL WITH A RECEPTOR
SITE
• ROC HAS 2 STATES - OPEN
CLOSED
eg: nicotinic Ach, Glutamate,
5HT3,GABA & Glycine
ION CHANNELS
VOLTAGE GATED CHANNEL:(VOC)
• Na channel - subunits
• P LOOP AND S4 HELIX
• LOCAL ANAESTHETICS,
ANTI-ARRYTHMICS
Na+ Channel
Ca 2+ CHANNEL
• WHEN MEMBRANE IS
DEPOLARISED -40mv
• 5 TYPES L , T , N, P & Q
CHANNELS
• L- TYPE CHANNEL ARE
BLOCKED BY CCBs.
K + CHANNEL
β
VOC K+
channel
• vascular and
smooth muscle
• opens when
membrane is
depolarised.
Ca2+ activated
K+ channel
• intracellular
ca2+increases , k+
influx-
repolarisation
• 5HT ,Ach ,NE
ATP sensitive
K+ channel
• cardiac muscle ,
beta cells of
pancreas.
• blocked by SUFI-
INSULIN release
by depolarisation.
Receptor Gated Channel:(ROC)
• LIGANDS- EXCITATORY NT-
Ach; Glutamate.
• INHIBITORY NT-
Glycine;GABA
• MAJORITY OF SYNAPSES IN
CNS &ANS.
• MEMBERS OF KV FAMILY
• cAMP GATED (HCN)
CHANNEL IN HEART
• CNG CHANNEL FOR VISION
• K ATP SENSITIVE CHANNEL IN
β CELLS OF PANCREAS -
INSULIN RELEASE BY
SULFONYLUREAS &
MEGLITINIDES.
• 5HT3
ANTAGONIST(ONDANSETR
ON) ON AFFERENT VAGAL
NERVES-
Insulin release
ATP INCREASE
BLOCKS K+
CHANNELS- WITH
SUBUNITS Kir6.2
and SUR1 WHICH
CAUSES CA2+
MEDIATED
EXOCYTOSIS OF
INSULIN RELEASE
FRON VESICLES.
ION CHANNEL-ROC-EXCITATORY
Ach Nicotinic NN receptor
• CNS, GANGLIA AND
NMJ(NM)
• PENTAMERIC 2 ,β,¥,θ
IN NMJ (NM ) whereas
2ɑ,3β in GANGLIA (NN)
• EACH SUBUNIT HAS 4
HELIXES
• EACH ɑ SUBUNIT HAS
Ach BINDING SITE
ION CHANNEL-ROC-EXCITATORY
Glutamate Receptor
• THEY ARE 5 IN NUMBER
• 3 IONOTROPHIC- NMDA
AMPA
KAINATE
• AP-4: INHIBITORY AUTO
RECEPTOR
ACPD: Metabotrophic Gq
AMPA & KAINATE- NON
NMDA RECEPTORS.
N-methyL-D-asparate(NMDA)
• ROC, PENTAMERIC
• NR1, NR2 SUBUNITS
• HAS 6 BINDING SITES
• HIGH PERMEABILITY TO
Ca 2 +AND Na+
MOA Anti epileptic drugs
• 1. Phenytoin, CBZ,
Valproate, lamotrigine,
lacosamide
• 2.Lamotrigine,GAbapen
tin,Pregabalin
• 3.FElbamate
• 4.Phenobaribitone,topir
amate,lamotrigine
• 7.Ethosuximide,
Valproate.
GABA
- inhibitory NT in cns.
- CL channel→hyperpolarisation
• GABAA - presynaptic
• IONOTROPIC
• GABAB- GPCR
• Pre & post synaptic
ca2+ inhibition, k+
opening
hyperpolarisation &
cAMP reduces.
• GLYCINE: Pentameric
• similar to GABA -Linked
to Cl -Channel.
TRANSMEMBRANE RECEPTORS
a) RECEPTOR TYROSINE
KINASES
• EPIDERMAL GROWTH
FACTOR
• INSULIN RECEPTORS
• PDGF,FGF,VEGF
b)TYROSINE KINASE
associated
• JAK-STAT
• SERINE-THREONINE
KINASES
• ANP RECEPTORS
• TOLL- LIKE RECEPTORS
• cGMP RECEPTORS
Receptor Tyrosine Kinase (RTK)
• a)aa
JANUS-KINASE -STAT
JAK PHOSPHORYLATES
STAT-SIGNAL
TRANDUCER AND
ACTIVATORS OF
TRANSCRIPTION.
4 JAK AND 6 STAT
eg: PROLACTIN -JAK1,2
AND STAT 5 FOR MILK
PRODUCTION.
GH, INF-¥
• SERINE-THREONINE
KINASES AT THE
CYTOPLASMIC DOMAIN
INSTEAD OF RTK.
• eg: TGF-β
• TYPE 1- 7 ISOFORMS
• TYPE 2- 5 FORMS
• SMAD PROTEINS
• INHIBITORY SMADS-6
AND 7.
TOLL-LIKE RECEPTORS
• INNATE IMMUNE SYSYTEM-
HAEMPOIETIC CELLS
• INTRACELLULAR DOMAIN IS
TIR DOMAIN
• LIGANDS- LIPIDS,
PEPTIDOGLYCANS,
LIPOPEPTIDES AND
VIRUSES.
• TNF-ɑ: TYPE 1, 2
• TRIMERIZATION- DEATH
DOMAIN is IC domain.
cGMP Receptors
• Guanylate cyclase is
transmembrane here
• ligands- ANP, NO
• Intracellular domain - GC
domain
• NO stimulates GC
→cGMP produced.
• EFFECTS: BP↓ , reduces
cardiac hypertrophy &
fibrosis.
Nuclear hormone Receptors
• cytosolic- steroids and sex
hormones
• Nuclear -TR, PPAR,
RXR,LXR,FXR, vitamin A & D
Receptors.
• heterodimers. slow & long
lasting process.
• Time for Gene Transcription:
• GPCR : Few sec to min
• Ion channels: milli seconds
• Tyrosine kinase :minutes
• nuclear: longer time
HISTAMINE
RECEPTORS
H1- Gq
H2-Gs
H3- Gi
H4-Gq/Go
SEROTONIN (5HT )RECEPTORS
5HT1
5HT1A,1B,1D,1E,1F
5HT2
2A,2B,2C
5HT3 5HT4, 5HT5A,B
5HT6,5HT7
Gi
↓ cAMP
Gq
↑PL-c
LIGAND GATED ION
CHANNEL
Gs
DOPAMINE RECEPTORS
D1-D5
VASOPRESSIN
RECEPTORS- ADH ACTS
D1- Gs -↑cAMP
D2-Gi -↓ cAMP
V1-Gq- ↑ PLc
V2- Gs- ↑c AMP
Regulation of receptors
• Receptor Desensitisation:Receptor mediated
response after initial high level, gradually
diminishes even in continuing presence of agonist.
• Down regulation: Prolonged exposure to high
concentration of agonist causes reduction in
number of receptors available for activation
• Up regulation:Prolonged occupation of receptors
by a antagonist leads to increase in number of
receptors-receptor sensitivity increases
• Denervation Supersensitivity: In Denervated
muscles, proliferation of new dopamine receptors
eg: tardive dyskinesia
Drug Receptors

More Related Content

What's hot

chronopharmacology.pptx
chronopharmacology.pptxchronopharmacology.pptx
chronopharmacology.pptx
vijay725262
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
Grandhi sandeep ganesh
 
Recent advancement in parkinson's disease
Recent advancement in parkinson's diseaseRecent advancement in parkinson's disease
Recent advancement in parkinson's disease
Rajesh Yadav
 
Safety Pharmacology
Safety PharmacologySafety Pharmacology
Safety Pharmacology
Pavana K A
 
Safety pharmacology ppt
Safety pharmacology pptSafety pharmacology ppt
Safety pharmacology ppt
Shilpa thakur
 
SlideShare on Traditional drug design methods
 SlideShare on Traditional drug design methods  SlideShare on Traditional drug design methods
SlideShare on Traditional drug design methods
Naveen K L
 
Herg assay,Structure, Various screening methods and Advantages
Herg assay,Structure,  Various screening methods and AdvantagesHerg assay,Structure,  Various screening methods and Advantages
Herg assay,Structure, Various screening methods and Advantages
Urvashi Shakarwal
 
pharmacophore mapping
pharmacophore mapping pharmacophore mapping
pharmacophore mapping
ashutosh mahale
 
Combinatorial chemistry and high throughput screening
Combinatorial chemistry and high throughput screeningCombinatorial chemistry and high throughput screening
Combinatorial chemistry and high throughput screening
Anji Reddy
 
Qsar parameters by ranjeeth k
Qsar parameters by ranjeeth kQsar parameters by ranjeeth k
Qsar parameters by ranjeeth k
RanjeethK2
 
industrial prespectives of IND
industrial prespectives of INDindustrial prespectives of IND
industrial prespectives of IND
Ravi Kumar katukuri
 
4 signal ligand gated ion channels.
4 signal ligand gated ion channels.4 signal ligand gated ion channels.
4 signal ligand gated ion channels.
Arunachalam Muthuraman
 
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
Satigayatri
 
De Novo Drug Design
De Novo Drug DesignDe Novo Drug Design
De Novo Drug Design
MAYANK ,MEHENDIRATTA
 
Presentation polymorphism affecting drug metabolism
Presentation polymorphism affecting drug metabolismPresentation polymorphism affecting drug metabolism
Presentation polymorphism affecting drug metabolism
LIGHTNING INDIA FOUNDATION FOR EXCILANCE
 
QSAR : Activity Relationships Quantitative Structure
QSAR : Activity Relationships Quantitative StructureQSAR : Activity Relationships Quantitative Structure
QSAR : Activity Relationships Quantitative Structure
Saramita De Chakravarti
 
Importance of si rna and micro rna
Importance of si rna and micro rnaImportance of si rna and micro rna
Importance of si rna and micro rna
Dr.SIBI P ITTIYAVIRAH
 
Rational drug design
Rational drug designRational drug design
Rational drug design
sathya sreehari
 
Chronopharmacology in asthma
Chronopharmacology in asthmaChronopharmacology in asthma
Chronopharmacology in asthma
Mohd Uzair Ansari
 
Guidelines for the preparation of protocol and documents in clnical trials
Guidelines for the preparation of protocol and documents in clnical trialsGuidelines for the preparation of protocol and documents in clnical trials
Guidelines for the preparation of protocol and documents in clnical trials
Sachin Kumar
 

What's hot (20)

chronopharmacology.pptx
chronopharmacology.pptxchronopharmacology.pptx
chronopharmacology.pptx
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
 
Recent advancement in parkinson's disease
Recent advancement in parkinson's diseaseRecent advancement in parkinson's disease
Recent advancement in parkinson's disease
 
Safety Pharmacology
Safety PharmacologySafety Pharmacology
Safety Pharmacology
 
Safety pharmacology ppt
Safety pharmacology pptSafety pharmacology ppt
Safety pharmacology ppt
 
SlideShare on Traditional drug design methods
 SlideShare on Traditional drug design methods  SlideShare on Traditional drug design methods
SlideShare on Traditional drug design methods
 
Herg assay,Structure, Various screening methods and Advantages
Herg assay,Structure,  Various screening methods and AdvantagesHerg assay,Structure,  Various screening methods and Advantages
Herg assay,Structure, Various screening methods and Advantages
 
pharmacophore mapping
pharmacophore mapping pharmacophore mapping
pharmacophore mapping
 
Combinatorial chemistry and high throughput screening
Combinatorial chemistry and high throughput screeningCombinatorial chemistry and high throughput screening
Combinatorial chemistry and high throughput screening
 
Qsar parameters by ranjeeth k
Qsar parameters by ranjeeth kQsar parameters by ranjeeth k
Qsar parameters by ranjeeth k
 
industrial prespectives of IND
industrial prespectives of INDindustrial prespectives of IND
industrial prespectives of IND
 
4 signal ligand gated ion channels.
4 signal ligand gated ion channels.4 signal ligand gated ion channels.
4 signal ligand gated ion channels.
 
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
 
De Novo Drug Design
De Novo Drug DesignDe Novo Drug Design
De Novo Drug Design
 
Presentation polymorphism affecting drug metabolism
Presentation polymorphism affecting drug metabolismPresentation polymorphism affecting drug metabolism
Presentation polymorphism affecting drug metabolism
 
QSAR : Activity Relationships Quantitative Structure
QSAR : Activity Relationships Quantitative StructureQSAR : Activity Relationships Quantitative Structure
QSAR : Activity Relationships Quantitative Structure
 
Importance of si rna and micro rna
Importance of si rna and micro rnaImportance of si rna and micro rna
Importance of si rna and micro rna
 
Rational drug design
Rational drug designRational drug design
Rational drug design
 
Chronopharmacology in asthma
Chronopharmacology in asthmaChronopharmacology in asthma
Chronopharmacology in asthma
 
Guidelines for the preparation of protocol and documents in clnical trials
Guidelines for the preparation of protocol and documents in clnical trialsGuidelines for the preparation of protocol and documents in clnical trials
Guidelines for the preparation of protocol and documents in clnical trials
 

Similar to Drug Receptors

Receptors and its classificationvpp
Receptors and its classificationvppReceptors and its classificationvpp
Receptors and its classificationvpp
Virupanagouda patil
 
G protein coupled receptor
G protein coupled receptorG protein coupled receptor
G protein coupled receptor
Fardan Qadeer
 
Receptor- ligand gated,enzyme linked, nuclear.
Receptor- ligand gated,enzyme linked, nuclear.Receptor- ligand gated,enzyme linked, nuclear.
Receptor- ligand gated,enzyme linked, nuclear.
MANISH mohan
 
Gprotei npptx
Gprotei npptxGprotei npptx
Gprotei npptx
DrSatyabrataSahoo
 
G protien coupled receptor by yatendra singh
G  protien coupled receptor by yatendra singhG  protien coupled receptor by yatendra singh
G protien coupled receptor by yatendra singh
Yatendra Singh
 
Signal transduction
Signal transductionSignal transduction
Signal transduction
Dr.M.Prasad Naidu
 
G protein coupled receptors
G protein coupled  receptorsG protein coupled  receptors
G protein coupled receptors
PavaniSSLD
 
Types of receptor
Types of receptorTypes of receptor
Types of receptor
Jaineel Dharod
 
Neuro 1.2
Neuro 1.2Neuro 1.2
Signal Transducer mechanisms
Signal Transducer mechanismsSignal Transducer mechanisms
Signal Transducer mechanisms
Koppala RVS Chaitanya
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
HariKrishnan835
 
Receptors 1
Receptors 1Receptors 1
Receptors 1
Sayeed Samrul
 
Receptors
ReceptorsReceptors
Receptors
Raju Sanghvi
 
GPCR
GPCRGPCR
Receotor
ReceotorReceotor
Receotor
Priya Nigan
 
G protein coupled receptor and pharmacotherapeutics
G protein coupled receptor and pharmacotherapeuticsG protein coupled receptor and pharmacotherapeutics
G protein coupled receptor and pharmacotherapeuticspriyanka527
 
Cell physiology1
Cell physiology1Cell physiology1

Similar to Drug Receptors (20)

Receptors and its classificationvpp
Receptors and its classificationvppReceptors and its classificationvpp
Receptors and its classificationvpp
 
G protein coupled receptor
G protein coupled receptorG protein coupled receptor
G protein coupled receptor
 
Receptor- ligand gated,enzyme linked, nuclear.
Receptor- ligand gated,enzyme linked, nuclear.Receptor- ligand gated,enzyme linked, nuclear.
Receptor- ligand gated,enzyme linked, nuclear.
 
Gprotei npptx
Gprotei npptxGprotei npptx
Gprotei npptx
 
G protien coupled receptor by yatendra singh
G  protien coupled receptor by yatendra singhG  protien coupled receptor by yatendra singh
G protien coupled receptor by yatendra singh
 
Signal transduction
Signal transductionSignal transduction
Signal transduction
 
Third messanger
Third messangerThird messanger
Third messanger
 
G protein coupled receptors
G protein coupled  receptorsG protein coupled  receptors
G protein coupled receptors
 
Second Messenger Systems
Second Messenger SystemsSecond Messenger Systems
Second Messenger Systems
 
Types of receptor
Types of receptorTypes of receptor
Types of receptor
 
Neuro 1.2
Neuro 1.2Neuro 1.2
Neuro 1.2
 
Signal Transducer mechanisms
Signal Transducer mechanismsSignal Transducer mechanisms
Signal Transducer mechanisms
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
 
Receptors-1
Receptors-1Receptors-1
Receptors-1
 
Receptors 1
Receptors 1Receptors 1
Receptors 1
 
Receptors
ReceptorsReceptors
Receptors
 
GPCR
GPCRGPCR
GPCR
 
Receotor
ReceotorReceotor
Receotor
 
G protein coupled receptor and pharmacotherapeutics
G protein coupled receptor and pharmacotherapeuticsG protein coupled receptor and pharmacotherapeutics
G protein coupled receptor and pharmacotherapeutics
 
Cell physiology1
Cell physiology1Cell physiology1
Cell physiology1
 

Recently uploaded

Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
Mohammed Sikander
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
thanhdowork
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 
The Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptxThe Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptx
DhatriParmar
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 

Recently uploaded (20)

Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 
The Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptxThe Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptx
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 

Drug Receptors

  • 1. DR. ARTHI POST GRADUATE MD PHARMACOLOGY RAJAH MUTHIAH MEDICAL COLLEGE
  • 2. . • CELLULAR MACROMOLECULAR COMPLEX WITH WHICH ITHE DRUG INTERACTS TO ELICIT A CELLULAR RESPONSE. • DRUGS CAN ACT EXTRACELLULAR, CELLULAR AND INTRACELLULAR. RECEPTOR • RECEPTOR - DRUG COMPLEX -EFFECTOR PROTEIN - SIGNAL TRANSDUCTIONSMECHANISM • AFFINITY ; INTRINSIC ACTIVITY OR EFFICACY • AGONIST ; ANTAGONIST • PARTIAL AGONIST ; INVERSE AGONIST TERMS
  • 3.
  • 4. TYPES OF RECEPTORS 1) G-PROTEIN COUPLED RECEPTORS (GPCR) 2) ION CHANNEL RECEPTORS - VOC AND ROC. 3) TRANS MEMBRANE RECEPTORS- RECEPTOR TYROSINE KINASES ; JAK- STAT; SERINE-THREONINE; TOLL-LIKE; TNF-α cGMP RECEPTORS 4) NUCLEAR RECEPTORS - CYTOSOLIC AND NUCLEAR
  • 5. G PROTEIN COUPLED RECEPTORS(METABOTROPIC) • 7 ALPHA HELICAL PROTEIN WITH 2 DOMAINS • HETEROTRIMERIC MOLECULE- α, β, ¥ SUBUNITS TIGHTLY BOUND TOGETHER WHICH OCCURS IN RESTING STATE • EFFECTOR MECHANISMS
  • 7. GS: ADENYLYL CYCLASE ACTIVATION, Ca CHANNEL OPENING Gi: ADENYLYL CYCLASE INHIBITON, K+ CHANNEL OPENING Go: Ca CHANNEL INHIBITION Gq: PHOSPHOLIPASE- C ACTIVATION- IP3 AND DAG. GPCR
  • 8. CYCLIC AMP • IS A PROTOTYPE SECOND MESSENGER FROM ADENYLYL CYCLASE. • cAMP INCREASED IN GS AND cAMP DECREASED IN Gi PATHWAYS. WHEN LIGAND(Adrenaline) BINDS TO GPCR, ↓ GS-α +GTP ↓ ACTIVATES ADENYLYL CYCLASE ↓ CAMP IS FORMED ↓ PHOSPHOKINASE A PHOSPHOKINASE A - PHOSPHORYLATES AND ALTERS THE FUNCTION OF MANY ENYMES, ION CHANNELS, TRANSPORTERS, TRANSCRIPTION FACTORS, STRUCTURAL PROTEINS.
  • 9.
  • 10. • β¥ DIMER- CAN REGULATE ION CHANNELS, PI3 KINASE • cAMP FUNCTIONS: a) cAMP RESPONSE ELEMENT BINDING PROTEIN b) CYCLIC NUCLEOTIDE GATED CA2+CHANNEL, PDES,SEVERAL ABC TRANSPORTERS MRP4 AND MRP5. c) REGULATES GUANINE NUCLEOTIDE EXCHANGE FACTORS (EPAC) • TERMINATION - BY PDES INTRACELLULARLY BY PDE3 AND PDE4. WHEREAS CGMP BY PDE5.
  • 11. PHOSPHOLIPASE C (PLC) ACTIVATED GTP WITH Gq-α SUBUNIT ↓ PIP2 PHOSPHORYLATION BY PLC ↓ SECOND MESSENGERS IP3 AND DAG ↓ DAG REMAINS IN MEMBRANE ;ACTIVATES PKC ALONG WITH ↓ Ca2+. IP3 MOBILISES Ca2+ FROM ER→Ca- CALMODULIN COMPLEX→EFFECTS→MLCK AND CCPK.
  • 12. PL-C HAS 2 ISOFORMS PLC-βACTIVATED BY GPCR PLC-¥ACTIVATED BY TYROSINE PHOSPHORYLATION
  • 13. ION CHANNELS ACTIVATED G- PROTEIN OPEN OR INHIBIT Ca OR K CHANNELS WITHOUT SECOND MESSENGERS. eg: M2 RECEPTORS IN CARDIAC - ↑ K+ PERMEABILITY. OPIODS REDUCE NEURONAL EXCITABILTY- K+ OPENING MUSCARINIC M1,M3, M5 M2, M4 Gq Gi,Go ADRENERGIC ɑ1 ɑ2 β Gq Gi,Go Gs DOPAMINE D1 D2 Gs Gi,Go SEROTONIN 5HT1 5HT2 Gi,Go Gq
  • 15. VOC ROC • MODULATED BY ALTERATIONS IN VOLTAGE GRADIENT • 3 STATES: OPEN CLOSED/BLOCKED INACTIVATED/REFRACTORY eg: Na+ channel; K +channel; Ca2+ channel • CHANNEL WITH A RECEPTOR SITE • ROC HAS 2 STATES - OPEN CLOSED eg: nicotinic Ach, Glutamate, 5HT3,GABA & Glycine ION CHANNELS
  • 16. VOLTAGE GATED CHANNEL:(VOC) • Na channel - subunits • P LOOP AND S4 HELIX • LOCAL ANAESTHETICS, ANTI-ARRYTHMICS
  • 18. Ca 2+ CHANNEL • WHEN MEMBRANE IS DEPOLARISED -40mv • 5 TYPES L , T , N, P & Q CHANNELS • L- TYPE CHANNEL ARE BLOCKED BY CCBs.
  • 19. K + CHANNEL β VOC K+ channel • vascular and smooth muscle • opens when membrane is depolarised. Ca2+ activated K+ channel • intracellular ca2+increases , k+ influx- repolarisation • 5HT ,Ach ,NE ATP sensitive K+ channel • cardiac muscle , beta cells of pancreas. • blocked by SUFI- INSULIN release by depolarisation.
  • 20. Receptor Gated Channel:(ROC) • LIGANDS- EXCITATORY NT- Ach; Glutamate. • INHIBITORY NT- Glycine;GABA • MAJORITY OF SYNAPSES IN CNS &ANS. • MEMBERS OF KV FAMILY • cAMP GATED (HCN) CHANNEL IN HEART • CNG CHANNEL FOR VISION • K ATP SENSITIVE CHANNEL IN β CELLS OF PANCREAS - INSULIN RELEASE BY SULFONYLUREAS & MEGLITINIDES. • 5HT3 ANTAGONIST(ONDANSETR ON) ON AFFERENT VAGAL NERVES-
  • 21. Insulin release ATP INCREASE BLOCKS K+ CHANNELS- WITH SUBUNITS Kir6.2 and SUR1 WHICH CAUSES CA2+ MEDIATED EXOCYTOSIS OF INSULIN RELEASE FRON VESICLES.
  • 22. ION CHANNEL-ROC-EXCITATORY Ach Nicotinic NN receptor • CNS, GANGLIA AND NMJ(NM) • PENTAMERIC 2 ,β,¥,θ IN NMJ (NM ) whereas 2ɑ,3β in GANGLIA (NN) • EACH SUBUNIT HAS 4 HELIXES • EACH ɑ SUBUNIT HAS Ach BINDING SITE
  • 23. ION CHANNEL-ROC-EXCITATORY Glutamate Receptor • THEY ARE 5 IN NUMBER • 3 IONOTROPHIC- NMDA AMPA KAINATE • AP-4: INHIBITORY AUTO RECEPTOR ACPD: Metabotrophic Gq AMPA & KAINATE- NON NMDA RECEPTORS.
  • 24. N-methyL-D-asparate(NMDA) • ROC, PENTAMERIC • NR1, NR2 SUBUNITS • HAS 6 BINDING SITES • HIGH PERMEABILITY TO Ca 2 +AND Na+
  • 25. MOA Anti epileptic drugs • 1. Phenytoin, CBZ, Valproate, lamotrigine, lacosamide • 2.Lamotrigine,GAbapen tin,Pregabalin • 3.FElbamate • 4.Phenobaribitone,topir amate,lamotrigine • 7.Ethosuximide, Valproate.
  • 26. GABA - inhibitory NT in cns. - CL channel→hyperpolarisation • GABAA - presynaptic • IONOTROPIC • GABAB- GPCR • Pre & post synaptic ca2+ inhibition, k+ opening hyperpolarisation & cAMP reduces. • GLYCINE: Pentameric • similar to GABA -Linked to Cl -Channel.
  • 27. TRANSMEMBRANE RECEPTORS a) RECEPTOR TYROSINE KINASES • EPIDERMAL GROWTH FACTOR • INSULIN RECEPTORS • PDGF,FGF,VEGF b)TYROSINE KINASE associated • JAK-STAT • SERINE-THREONINE KINASES • ANP RECEPTORS • TOLL- LIKE RECEPTORS • cGMP RECEPTORS
  • 28. Receptor Tyrosine Kinase (RTK) • a)aa
  • 29. JANUS-KINASE -STAT JAK PHOSPHORYLATES STAT-SIGNAL TRANDUCER AND ACTIVATORS OF TRANSCRIPTION. 4 JAK AND 6 STAT eg: PROLACTIN -JAK1,2 AND STAT 5 FOR MILK PRODUCTION. GH, INF-¥
  • 30. • SERINE-THREONINE KINASES AT THE CYTOPLASMIC DOMAIN INSTEAD OF RTK. • eg: TGF-β • TYPE 1- 7 ISOFORMS • TYPE 2- 5 FORMS • SMAD PROTEINS • INHIBITORY SMADS-6 AND 7.
  • 31. TOLL-LIKE RECEPTORS • INNATE IMMUNE SYSYTEM- HAEMPOIETIC CELLS • INTRACELLULAR DOMAIN IS TIR DOMAIN • LIGANDS- LIPIDS, PEPTIDOGLYCANS, LIPOPEPTIDES AND VIRUSES. • TNF-ɑ: TYPE 1, 2 • TRIMERIZATION- DEATH DOMAIN is IC domain.
  • 32. cGMP Receptors • Guanylate cyclase is transmembrane here • ligands- ANP, NO • Intracellular domain - GC domain • NO stimulates GC →cGMP produced. • EFFECTS: BP↓ , reduces cardiac hypertrophy & fibrosis.
  • 33. Nuclear hormone Receptors • cytosolic- steroids and sex hormones • Nuclear -TR, PPAR, RXR,LXR,FXR, vitamin A & D Receptors. • heterodimers. slow & long lasting process.
  • 34. • Time for Gene Transcription: • GPCR : Few sec to min • Ion channels: milli seconds • Tyrosine kinase :minutes • nuclear: longer time
  • 36. SEROTONIN (5HT )RECEPTORS 5HT1 5HT1A,1B,1D,1E,1F 5HT2 2A,2B,2C 5HT3 5HT4, 5HT5A,B 5HT6,5HT7 Gi ↓ cAMP Gq ↑PL-c LIGAND GATED ION CHANNEL Gs DOPAMINE RECEPTORS D1-D5 VASOPRESSIN RECEPTORS- ADH ACTS D1- Gs -↑cAMP D2-Gi -↓ cAMP V1-Gq- ↑ PLc V2- Gs- ↑c AMP
  • 37. Regulation of receptors • Receptor Desensitisation:Receptor mediated response after initial high level, gradually diminishes even in continuing presence of agonist. • Down regulation: Prolonged exposure to high concentration of agonist causes reduction in number of receptors available for activation • Up regulation:Prolonged occupation of receptors by a antagonist leads to increase in number of receptors-receptor sensitivity increases • Denervation Supersensitivity: In Denervated muscles, proliferation of new dopamine receptors eg: tardive dyskinesia